TCG Crossover GP II, LLC - 09 Jan 2026 SCHEDULE 13G Report for Century Therapeutics, Inc. Common Stock, par value $0.0001 per share (IPSC)

Filing Manager
TCG Crossover GP II, LLC
Reporting Manager
Chen Yu
Security
Century Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
IPSC
Shares outstanding
179,337,677 shares
Disclosed Ownership
17,754,430 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
15 Jan 2026, 16:19:57 UTC
Date of event
09 Jan 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"TCG Crossover GP II, LLC disclosed 9.9% ownership in Century Therapeutics, Inc. Common Stock, par value $0.0001 per share (IPSC) on 09 Jan 2026."

Quick Takeaways

  • TCG Crossover GP II, LLC filed SCHEDULE 13G for Century Therapeutics, Inc. Common Stock, par value $0.0001 per share (IPSC).
  • Disclosed ownership: 9.9%.
  • Date of event: 09 Jan 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 Jan 2026, 16:19.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP II, LLC 4.9% 8,877,215 0 8,877,215 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund II, L.P. 4.9% 8,877,215 0 8,877,215 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover GP III, LLC 4.9% 8,877,215 0 8,877,215 /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund III, L.P. 4.9% 8,877,215 0 8,877,215 /s/ Craig Skaling Craig Skaling, Authorized Signatory
Chen Yu 9.9% 17,754,430 0 17,754,430 /s/ Craig Skaling Craig Skaling, as Attorney-in-Fact for Chen Yu

Sponsored